{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T20:48:53Z","timestamp":1793825333949,"version":"4.6.1"},"reference-count":65,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T00:00:00Z","timestamp":1780099200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T00:00:00Z","timestamp":1785888000000},"content-version":"vor","delay-in-days":67,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["2020M671541"],"award-info":[{"award-number":["2020M671541"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Top Talent Support Program for Young and Middle-aged People of Wuxi Health Committee","award":["BJ2023017"],"award-info":[{"award-number":["BJ2023017"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"DOI":"10.1186\/s12967-026-08356-y","type":"journal-article","created":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T05:46:54Z","timestamp":1780292814000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["FTO-modulated m6A demethylation and upregulation of KIF11 mRNA promotes retinal microvascular dysfunction in diabetic retinopathy"],"prefix":"10.1186","volume":"24","author":[{"given":"Chenyu","family":"Lin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenyang","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shujing","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinyi","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Xin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3477-4568","authenticated-orcid":false,"given":"Jun","family":"Shao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,30]]},"reference":[{"issue":"10467","key":"8356_CR1","doi-asserted-by":"publisher","first-page":"2077","DOI":"10.1016\/S0140-6736(24)02317-1","volume":"404","author":"NCD Risk Factor Collaboration","year":"2024","unstructured":"NCD Risk Factor Collaboration. Worldwide trends in diabetes prevalence and treatment from 1990 to 2022: a pooled analysis of 1108 population-representative studies with 141 million participants. Lancet. 2024;404(10467):2077\u201393.","journal-title":"Lancet"},{"key":"8356_CR2","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/s12916-025-03890-w","volume":"23","author":"X Chen","year":"2025","unstructured":"Chen X, Zhang L, Chen W. Global, regional, and national burdens of type 1 and type 2 diabetes mellitus in adolescents from 1990 to 2021, with forecasts to 2030: a systematic analysis of the global burden of disease study 2021. BMC Med. 2025;23:48.","journal-title":"BMC Med"},{"issue":"12","key":"8356_CR3","doi-asserted-by":"publisher","first-page":"e1089","DOI":"10.1016\/S2468-2667(24)00250-0","volume":"9","author":"Y Xu","year":"2024","unstructured":"Xu Y, Lu JL, Li M, Wang TG, Wang K, Cao QY, Ding Y, Xiang Y, Wang SY, Yang QQ, Zhao X, Zhang XY, Xu M, Wang WQ, Bi YF, Ning G. Diabetes in China part 1: epidemiology and risk factors. Lancet Public Health. 2024;9(12):e1089\u201397.","journal-title":"Lancet Public Health"},{"issue":"8","key":"8356_CR4","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1001\/jamaophthalmol.2023.2289","volume":"141","author":"EA Lundeen","year":"2023","unstructured":"Lundeen EA, Burke-Conte Z, Rein DB, Wittenborn JS, Saaddine J, Lee AY, Flaxman AD. Prevalence of Diabetic Retinopathy in the US in 2021. JAMA Ophthalmol. 2023;141(8):747\u201354.","journal-title":"JAMA Ophthalmol"},{"issue":"1","key":"8356_CR5","doi-asserted-by":"publisher","first-page":"4296","DOI":"10.1038\/s41467-023-39864-w","volume":"14","author":"XH Hou","year":"2023","unstructured":"Hou XH, Wang LM, Zhu DL, Guo LX, Weng JP, Zhang M, Zhou ZG, Zou DJ, Ji QH, Guo XH, Wu Q, Chen SY, Yu R, Chen HL, Huang ZJ, Zhang X, Wu JR, Wu J, Jia WP. China National Diabetic Chronic Complications (DiaChronic) Study Group. Prevalence of diabetic retinopathy and vision-threatening diabetic retinopathy in adults with diabetes in China. Nat Commun. 2023;14(1):4296.","journal-title":"Nat Commun"},{"issue":"6","key":"8356_CR6","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1038\/s41433-025-03633-4","volume":"39","author":"A Irodi","year":"2025","unstructured":"Irodi A, Zhu ZT, Grzybowski A, Wu YL, Cheung CY, Li HT, Tan G, Wong TY. The evolution of diabetic retinopathy screening. Eye (Lond). 2025;39(6):1040\u20136.","journal-title":"Eye (Lond)"},{"issue":"1","key":"8356_CR7","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1186\/s12886-023-03118-6","volume":"23","author":"HB Li","year":"2023","unstructured":"Li HB, Liu XY, Zhong H, Fang JN, Li XN, Shi R, Yu Q. Research progress on the pathogenesis of diabetic retinopathy. BMC Ophthalmol. 2023;23(1):372.","journal-title":"BMC Ophthalmol"},{"issue":"8","key":"8356_CR8","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1001\/jamaophthalmol.2023.2558","volume":"141","author":"XR Kong","year":"2023","unstructured":"Kong XR. Diabetic Retinopathy in the US\u2014Where We Are Now and What Is Next. JAMA Ophthalmol. 2023;141(8):754\u20135.","journal-title":"JAMA Ophthalmol"},{"issue":"2","key":"8356_CR9","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.tcm.2022.11.003","volume":"34","author":"O Tomkins-Netzer","year":"2024","unstructured":"Tomkins-Netzer O, Niederer R, Lightman S. The role of statins in diabetic retinopathy. Trends Cardiovasc Med. 2024;34(2):128\u201335.","journal-title":"Trends Cardiovasc Med"},{"issue":"6","key":"8356_CR10","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1016\/j.survophthal.2024.07.001","volume":"69","author":"SH Sinclair","year":"2024","unstructured":"Sinclair SH, Schwartz S. Diabetic retinopathy: New concepts of screening, monitoring, and interventions. Surv Ophthalmol. 2024;69(6):882\u201392.","journal-title":"Surv Ophthalmol"},{"issue":"2","key":"8356_CR11","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1038\/nsmb.3162","volume":"23","author":"N Liu","year":"2016","unstructured":"Liu N, Pan T. N6-methyladenosine-encoded epitranscriptomics. Nat Struct Mol Biol. 2016;23(2):98\u2013102.","journal-title":"Nat Struct Mol Biol"},{"issue":"4","key":"8356_CR12","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1016\/j.molcel.2019.04.025","volume":"74","author":"H Shi","year":"2019","unstructured":"Shi H, Wei J, He C. Where, when, and how: context-dependent functions of RNA methylation writers, readers, and erasers. Mol Cell. 2019;74(4):640\u201350.","journal-title":"Mol Cell"},{"issue":"6","key":"8356_CR13","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1038\/s41422-018-0040-8","volume":"28","author":"Y Yang","year":"2018","unstructured":"Yang Y, Hsu PG, Chen YS, Yang YG. Dynamic transcriptomic m(6)A decoration: writers, erasers, readers and functions in RNA metabolism. Cell Res. 2018;28(6):616\u201324.","journal-title":"Cell Res"},{"issue":"1","key":"8356_CR14","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1038\/nrm.2016.132","volume":"18","author":"BS Zhao","year":"2017","unstructured":"Zhao BS, Roundtree IA, He C. Post-transcriptional gene regulation by mRNA modifications. Nat Rev Mol Cell Biol. 2017;18(1):31\u201342.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"1","key":"8356_CR15","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1038\/s41392-020-00450-x","volume":"6","author":"XL Jiang","year":"2021","unstructured":"Jiang XL, Liu BY, Nie Z, Duan LC, Xiong QX, Jin ZX, Yang CP, Chen YB. The role of m6A modification in the biological functions and diseases. Signal Transduct Target Ther. 2021;6(1):74.","journal-title":"Signal Transduct Target Ther"},{"issue":"1","key":"8356_CR16","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1186\/s12943-020-01204-7","volume":"19","author":"TY Wang","year":"2020","unstructured":"Wang TY, Kong S, Tao M, Ju SQ. The potential role of RNA N6-methyladenosine in Cancer progression. Mol Cancer. 2020;19(1):88.","journal-title":"Mol Cancer"},{"issue":"8","key":"8356_CR17","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1038\/s41419-024-06931-z","volume":"15","author":"L Zhao","year":"2024","unstructured":"Zhao L, Li QH, Zhou TL. Role of N6-methyladenosine in tumor neovascularization. Cell Death Dis. 2024;15(8):563.","journal-title":"Cell Death Dis"},{"issue":"488","key":"8356_CR18","doi-asserted-by":"publisher","first-page":"eaau7116","DOI":"10.1126\/scitranslmed.aau7116","volume":"11","author":"SM Peng","year":"2019","unstructured":"Peng SM, Xiao W, Ju DP, Sun BF, Hou NN, Liu QL, Wang YL, Zhao HJ, Gao CC, Zhang S, Cao R, Li PF, Huang HW, Ma YF, Wang YK, Lai WY, Ma ZX, Zhang W, Huang S, Wang HL, Zhang ZY, Zhao LP, Cai T, Zhao YL, Wang FC, Nie YZ, Zhi G, Yang YG, Zhang EE, Huang N. Identification of entacapone as a chemical inhibitor of FTO mediating metabolic regulation through FOXO1. Sci Transl Med. 2019;11(488):eaau7116.","journal-title":"Sci Transl Med"},{"issue":"51","key":"8356_CR19","doi-asserted-by":"publisher","first-page":"e2407910121","DOI":"10.1073\/pnas.2407910121","volume":"121","author":"YH Cui","year":"2024","unstructured":"Cui YH, Wei JB, Fan H, Li WL, Zhao LJ, Wilkinson E, Peterson J, Xie LS, Zou ZY, Yang SW, Applebaum MA, Kline J, Chen J, He C, He YY. Targeting DTX2\/UFD1-mediated FTO degradation to regulate antitumor immunity. Proc Natl Acad Sci U S A. 2024;121(51):e2407910121.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"8356_CR20","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1038\/s41467-025-56615-1","volume":"16","author":"YJ Qian","year":"2025","unstructured":"Qian YJ, Wu J, Yang WD, Lyu RN, You Q, Li JJ, He Q, Zhuang Y, Wang WM, Wang Y, Zhu YN, Wu ZW, Chen DY. FTO-associated osteoclastogenesis promotes alveolar bone resorption in apical periodontitis male rat via the HK1\/USP14\/RANK pathway. Nat Commun. 2025;16(1):1519.","journal-title":"Nat Commun"},{"issue":"1","key":"8356_CR21","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1186\/s12943-024-02117-5","volume":"23","author":"YZ Zou","year":"2024","unstructured":"Zou YZ, Bao XQ, Li DP, Ye Z, Xiang R, Yang YZ, Zhu Z, Chen ZM, Zeng LX, Xue CL, Zhao HZ, Yao BY, Zhang QL, Yan ZM, Deng ZK, Cheng JT, Yue GH, Hu WM, Zhao JX, Bai RH, Zhang ZH, Liu AQ, Zhang JL, Zuo ZX, Jiang XB. FTO-mediated DSP m6A demethylation promotes an aggressive subtype of growth hormone-secreting pituitary neuroendocrine tumors. Mol Cancer. 2024;23(1):205.","journal-title":"Mol Cancer"},{"issue":"19","key":"8356_CR22","doi-asserted-by":"publisher","first-page":"e160517","DOI":"10.1172\/JCI160517","volume":"133","author":"CD Zhou","year":"2023","unstructured":"Zhou CD, She XP, Gu CF, Hu YN, Ma MM, Qiu QH, Sun T, Xu X, Chen HB, Zheng Z. FTO fuels diabetes-induced vascular endothelial dysfunction associated with inflammation by erasing m6A methylation of TNIP1. J Clin Invest. 2023;133(19):e160517.","journal-title":"J Clin Invest"},{"issue":"2","key":"8356_CR23","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1038\/s44321-024-00025-1","volume":"16","author":"X Chen","year":"2024","unstructured":"Chen X, Wang Y, Wang JN, Zhang YC, Zhang YR, Sun RX, Qin B, Dai YX, Zhu HJ, Zhao JX, Zhang WW, Ji JD, Yuan ST, Shen QD, Liu QH. Lactylation-driven FTO targets CDK2 to aggravate microvascular anomalies in diabetic retinopathy. EMBO Mol Med. 2024;16(2):294\u2013318.","journal-title":"EMBO Mol Med"},{"issue":"1","key":"8356_CR24","doi-asserted-by":"publisher","first-page":"82","DOI":"10.2337\/db24-0691","volume":"74","author":"SG Feng","year":"2025","unstructured":"Feng SG, Zhang QY, Liu Q, Huang C, Zhang HY, Wang FS, Zhu Y, Jian QZ, Chen X, Jiang Q, Yan B. N6-Methyladenosine Demethylase FTO Controls Macrophage Homeostasis in Diabetic Vasculopathy. Diabetes. 2025;74(1):82\u201395.","journal-title":"Diabetes"},{"issue":"1","key":"8356_CR25","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1007\/s11033-025-10400-x","volume":"52","author":"Q Cheng","year":"2025","unstructured":"Cheng Q, Zhou LQ, Fan XY, Ma MJ, Zhang CH, Zha X, Zhang YP. FTO-mediated Nrf2 demethylation alleviates high glucose-induced oxidative stress and apoptosis in retinal pigment epithelial cells. Mol Biol Rep. 2025;52(1):289.","journal-title":"Mol Biol Rep"},{"issue":"1","key":"8356_CR26","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1186\/s12920-019-0596-2","volume":"12","author":"J Shao","year":"2019","unstructured":"Shao J, Zhang YB, Fan GM, Xin Y, Yao Y. Transcriptome analysis identified a novel 3-LncRNA regulatory network of transthyretin attenuating glucose induced hRECs dysfunction in diabetic retinopathy. BMC Med Genomics. 2019;12(1):134.","journal-title":"BMC Med Genomics"},{"issue":"1","key":"8356_CR27","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/s12967-025-06081-6","volume":"23","author":"B Wang","year":"2025","unstructured":"Wang B, Bao L, Li X, Sun G, Yang W, Xie NZ, Lei L, Chen W, Zhang HL, Chen M, Zhao X, Wan XF, Yuan R, Jiang HM. Identification and validation of the important role of KIF11 in the development and progression of endometrial cancer. J Transl Med. 2025;23(1):48.","journal-title":"J Transl Med"},{"key":"8356_CR28","doi-asserted-by":"publisher","first-page":"102118","DOI":"10.1016\/j.tranon.2024.102118","volume":"50","author":"XL Wang","year":"2024","unstructured":"Wang XL, He X, Gao T, Zhou XY, Cruz-Monserrate Z, Tsung A, Ma JJ, Cai CX. MG53 suppresses tumor growth via transcriptional inhibition of KIF11 in pancreatic cancer. Transl Oncol. 2024;50:102118.","journal-title":"Transl Oncol"},{"issue":"1","key":"8356_CR29","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1186\/s12967-025-06124-y","volume":"23","author":"ZY Wu","year":"2025","unstructured":"Wu ZY, Li C, Zhang SH, Sun L, Hu JW, Qiu BB, Liu SQ, Hong YR, Chen TX, Wang K, Yin XB, Yan JL. High interstitial fluid pressure enhances USP1-dependent KIF11 protein stability to promote hepatocellular carcinoma progression. J Transl Med. 2025;23(1):66.","journal-title":"J Transl Med"},{"key":"8356_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.canlet.2021.02.016","volume":"506","author":"G Jungwirth","year":"2021","unstructured":"Jungwirth G, Yu T, Cao JG, Eddine MA, Moustafa M, Warta R, Debus J, Unterberg A, Abdollahi A, Herold-Mende C. KIF11 inhibitors filanesib and ispinesib inhibit meningioma growth in vitro and in vivo. Cancer Lett. 2021;506:1\u201310.","journal-title":"Cancer Lett"},{"issue":"1","key":"8356_CR31","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1186\/s12886-020-01381-5","volume":"20","author":"DW Shao","year":"2020","unstructured":"Shao DW, He SZ, Ye Z, Zhu XQ, Sun W, Fu W, Ma TJ, Li ZH. Identification of potential molecular targets associated with proliferative diabetic retinopathy. BMC Ophthalmol. 2020;20(1):143.","journal-title":"BMC Ophthalmol"},{"issue":"4","key":"8356_CR32","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1016\/j.ccell.2019.03.006","volume":"35","author":"Y Huang","year":"2019","unstructured":"Huang Y, Su R, Sheng Y, Dong L, Dong Z, Xu H, Ni T, Zhang ZS, Zhang T, Li C, Han L, Zhu Z, Lian F, Wei J, Deng Q, Wang Y, Wunderlich M, Gao Z, Pan G, Zhong D, Zhou H, Zhang N, Gan J, Jiang H, Mulloy JC, Qian Z, Chen J, Yang CG. Small-Molecule Targeting of Oncogenic FTO Demethylase in Acute Myeloid Leukemia. Cancer Cell. 2019;35(4):677\u2013e69110.","journal-title":"Cancer Cell"},{"key":"8356_CR33","doi-asserted-by":"publisher","first-page":"112042","DOI":"10.1016\/j.mce.2023.112042","volume":"576","author":"J Shao","year":"2023","unstructured":"Shao J, Gu WD, Ye L, Xin Y. The hsa_circ_0004805\/hsa_miR-149-5p\/TGFB2 axis plays critical roles in the pathophysiology of diabetic retinopathy in vitro and in vivo. Mol Cell Endocrinol. 2023;576:112042.","journal-title":"Mol Cell Endocrinol"},{"issue":"1","key":"8356_CR34","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1186\/s12967-025-06437-y","volume":"23","author":"YX Chen","year":"2025","unstructured":"Chen YX, Ye L, Cui SJ, Shao J, Xin Y. Peptides based on the interface of hnRNPA2B1-transthyretin complex repress retinal angiogenesis in diabetic retinopathy. J Transl Med. 2025;23(1):458.","journal-title":"J Transl Med"},{"key":"8356_CR35","doi-asserted-by":"publisher","first-page":"386","DOI":"10.3390\/biom14040386","volume":"14","author":"WT Gao","year":"2024","unstructured":"Gao WT, Lu JJ, Yang ZT, Li EM, Cao YF, Xie L. Mitotic functions and characters of KIF11 in cancers. Biomolecules. 2024;14:386.","journal-title":"Biomolecules"},{"issue":"3","key":"8356_CR36","first-page":"CD008721","volume":"3","author":"MJ Martinez-Zapata","year":"2023","unstructured":"Martinez-Zapata MJ, Salvador I, Mart\u00ed-Carvajal AJ, Pijoan JI, Cordero JA, Ponomarev D, Kernohan A, Sol\u00e0 I, Virgili G. Anti-vascular endothelial growth factor for proliferative diabetic retinopathy. Cochrane Database Syst Rev. 2023;3(3):CD008721.","journal-title":"Cochrane Database Syst Rev"},{"issue":"14","key":"8356_CR37","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1080\/14656566.2023.2230139","volume":"24","author":"SM Muns","year":"2023","unstructured":"Muns SM, Villegas VM, Flynn HW, Schwartz SG. Update on current pharmacologic therapies for diabetic retinopathy. Expert Opin Pharmacother. 2023;24(14):1577\u201393.","journal-title":"Expert Opin Pharmacother"},{"issue":"5","key":"8356_CR38","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1167\/iovs.64.5.28","volume":"64","author":"D Sharma","year":"2023","unstructured":"Sharma D, Zachary I, Jia HY. Mechanisms of Acquired Resistance to Anti-VEGF Therapy for Neovascular Eye Diseases. Invest Ophthalmol Vis Sci. 2023;64(5):28.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"8356_CR39","doi-asserted-by":"crossref","unstructured":"Liu Y, Sun ZY, Gui DK, Zhao YH, Xu YH. RNA modification in metabolism. MedComm (2020). 2025;6(3):e70135.","DOI":"10.1002\/mco2.70135"},{"key":"8356_CR40","doi-asserted-by":"publisher","first-page":"1693336","DOI":"10.3389\/fimmu.2025.1693336","volume":"16","author":"X Chen","year":"2025","unstructured":"Chen X, Pu SR, Lian K, Li LH, Jiang XL. m6A RNA modification in tumor-associated macrophages: emerging roles in cancer immunity. Front Immunol. 2025;16:1693336.","journal-title":"Front Immunol"},{"issue":"1","key":"8356_CR41","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1186\/s12964-025-02254-4","volume":"23","author":"YY Han","year":"2025","unstructured":"Han YY, Sun JQ, Yao MH, Miao LY, Li MJ. Biological roles of enhancer RNA m6A modification and its implications in cancer. Cell Commun Signal. 2025;23(1):254.","journal-title":"Cell Commun Signal"},{"issue":"2","key":"8356_CR42","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1038\/s41593-024-01850-w","volume":"28","author":"TB Nguyen","year":"2025","unstructured":"Nguyen TB, Miramontes R, Chillon-Marinas C, Maimon R, Vazquez-Sanchez S, Lau AL, McClure NR, Wu ZX, Wang KQ, England WE, Singha M, Stocksdale JT, Heath M, Jang KH, Jung SH, Ling K, Jafar-Nejad P, McKnight JI, Ho LN, Dalahmah OA, Faull RLM, Steffan JS, Reidling JC, Jang C, Lee G, Cleveland DW, Lagier-Tourenne C, Spitale RC, Thompson LM. Aberrant splicing in Huntington\u2019s disease accompanies disrupted TDP-43 activity and altered m6A RNA modification. Nat Neurosci. 2025;28(2):280\u201392.","journal-title":"Nat Neurosci"},{"issue":"5","key":"8356_CR43","doi-asserted-by":"publisher","first-page":"617","DOI":"10.3390\/biom15050617","volume":"15","author":"YL Wang","year":"2025","unstructured":"Wang YL, Zhao TY, Yuan CS, Chen XC. The Role of N6-Methyladenosine (m6A) RNA Modification in the Pathogenesis of Parkinson\u2019s Disease. Biomolecules. 2025;15(5):617.","journal-title":"Biomolecules"},{"issue":"2","key":"8356_CR44","doi-asserted-by":"publisher","first-page":"qzae049","DOI":"10.1093\/gpbjnl\/qzae049","volume":"23","author":"WD Liu","year":"2025","unstructured":"Liu WD, Wang YH, Yao SX, HanGQ, Hu J, Yin R, Zhou FL, Cheng Y, Zhang HJ. Reprogramming of RNA m6A Modification Is Required for Acute Myeloid Leukemia Development. Genomics Proteom Bioinf. 2025;23(2):qzae049.","journal-title":"Genomics Proteom Bioinf"},{"issue":"17","key":"8356_CR45","doi-asserted-by":"publisher","first-page":"2236","DOI":"10.1093\/cvr\/cvae239","volume":"120","author":"JF Ding","year":"2024","unstructured":"Ding JF, Tu B, Song K, Liu ZY, Lin LC, Liu ZY, Shi Y, Yang JJ, Zhao JY, Tao H. Epitranscriptomic regulation of cardiac fibrosis via YTHDF1-dependent PIEZO2 mRNA m6A modification. Cardiovasc Res. 2024;120(17):2236\u201348.","journal-title":"Cardiovasc Res"},{"issue":"12","key":"8356_CR46","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1016\/j.tips.2023.09.013","volume":"44","author":"LC Lin","year":"2023","unstructured":"Lin LC, Liu ZY, Yang JJ, Zhao JY, Tao H. m6A epitranscriptomic modification in diabetic microvascular complications. Trends Pharmacol Sci. 2023;44(12):991\u20131008.","journal-title":"Trends Pharmacol Sci"},{"key":"8356_CR47","doi-asserted-by":"publisher","first-page":"111873","DOI":"10.1016\/j.biopha.2021.111873","volume":"141","author":"M Malekan","year":"2021","unstructured":"Malekan M, Ebrahimzadeh MA, Sheida F. The role of Hypoxia-Inducible Factor-1alpha and its signaling in melanoma. Biomed Pharmacother. 2021;141:111873.","journal-title":"Biomed Pharmacother"},{"issue":"2","key":"8356_CR48","doi-asserted-by":"publisher","first-page":"106","DOI":"10.3390\/curroncol32020106","volume":"32","author":"AVS Geetha","year":"2025","unstructured":"Geetha AVS, Harithpriya K, Ganesan K, Ramkumar KM. Exploring the Role of Hypoxia and HIF-1\u03b1 in the Intersection of Type 2 Diabetes Mellitus and Endometrial Cancer. Curr Oncol. 2025;32(2):106.","journal-title":"Curr Oncol"},{"issue":"8","key":"8356_CR49","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.32604\/or.2024.052130","volume":"32","author":"DP Vageli","year":"2024","unstructured":"Vageli DP, Doukas PG, Goupou K, Benos AD, Astara K, Zacharouli K, Sotiriou S, Ioannou M. Hypoxia-inducible factor 1alpha and vascular endothelial growth factor in Glioblastoma Multiforme: a systematic review going beyond pathologic implications. Oncol Res. 2024;32(8):1239\u201356.","journal-title":"Oncol Res"},{"issue":"1","key":"8356_CR50","doi-asserted-by":"publisher","first-page":"3286","DOI":"10.1080\/07853890.2022.2146744","volume":"54","author":"JB Mao","year":"2022","unstructured":"Mao JB, Chen YJ, Fang YY, Shao YR, Xiang ZY, Li HX, Zhao SX, Chen YQ, Shen LJ. Clinical characteristics and mutation spectrum in 33 Chinese families with familial exudative vitreoretinopathy. Ann Med. 2022;54(1):3286\u201398.","journal-title":"Ann Med"},{"key":"8356_CR51","doi-asserted-by":"crossref","unstructured":"Jiang MY, Zhang K, Zhang ZW, Zeng XR, Huang ZH, Qin PZ, Xie ZL, Cai X, Ashrafizadeh M, Tian Y, Wei RQ. PI3K\/AKT\/mTOR axis in cancer: from pathogenesis to treatment. MedComm (2020). 2025;6(8): e70295.","DOI":"10.1002\/mco2.70295"},{"issue":"5","key":"8356_CR52","doi-asserted-by":"publisher","first-page":"1932","DOI":"10.7150\/ijbs.104598","volume":"21","author":"YF Yin","year":"2025","unstructured":"Yin YF, Sun YX, Yao HF, Yu F, Jia QY, Hu CY, Zhu YH, Duan ZH, Liu DJ, Sun YW, Huo YM, Yang MW, Liu W. TMEM105 modulates disulfidptosis and tumor growth in pancreatic cancer via the beta-catenin-c-MYC-GLUT1 axis. Int J Biol Sci. 2025;21(5):1932\u201348.","journal-title":"Int J Biol Sci"},{"issue":"2","key":"8356_CR53","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1038\/s44321-024-00025-1","volume":"16","author":"X Chen","year":"2024","unstructured":"Chen X, Wang Y, Wang JN, Zhang YC, Zhang YR, Sun RX, Qin B, Dai YX, Zhu HJ, Zhao JX, Zhang WW, Ji JD, Yuan ST, Shen QD, Liu QH. Lactylation-driven FTO targets CDK2 to aggravate microvascular anomalies in diabetic retinopathy. EMBO Mol Med. 2024;16(2):294\u2013318.","journal-title":"EMBO Mol Med"},{"issue":"7","key":"8356_CR54","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1016\/j.trecan.2022.02.010","volume":"8","author":"YC Li","year":"2022","unstructured":"Li YC, Su R, Deng XL, Chen Y, Chen JJ. FTO in cancer: functions, molecular mechanisms, and therapeutic implications. Trends Cancer. 2022;8(7):598\u2013614.","journal-title":"Trends Cancer"},{"issue":"1","key":"8356_CR55","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1038\/s41392-020-00450-x","volume":"6","author":"XL Jiang","year":"2021","unstructured":"Jiang XL, Liu BY, Nie Z, Duan LC, Xiong QX, Jin ZX, Yang CP, Chen YB. The role of m6A modification in the biological functions and diseases. Signal Transduct Target Ther. 2021;6(1):74.","journal-title":"Signal Transduct Target Ther"},{"key":"8356_CR56","doi-asserted-by":"publisher","first-page":"1500394","DOI":"10.3389\/fcell.2024.1500394","volume":"12","author":"D Benak","year":"2024","unstructured":"Benak D, Sevcikova A, Holzerova K, Hlavackova M. FTO in health and disease. Front Cell Dev Biol. 2024;12:1500394.","journal-title":"Front Cell Dev Biol"},{"issue":"12","key":"8356_CR57","doi-asserted-by":"publisher","first-page":"2201","DOI":"10.1158\/0008-5472.CAN-21-3710","volume":"82","author":"HR Zuidhof","year":"2022","unstructured":"Zuidhof HR, Calkhoven CF. Oncogenic and Tumor-Suppressive Functions of the RNA Demethylase FTO. Cancer Res. 2022;82(12):2201\u201312.","journal-title":"Cancer Res"},{"issue":"5","key":"8356_CR58","doi-asserted-by":"publisher","first-page":"1352","DOI":"10.1039\/D1CB00075F","volume":"2","author":"LL Zhou","year":"2021","unstructured":"Zhou LL, Xu H, Huang Y, Yang CG. Targeting the RNA demethylase FTO for cancer therapy. RSC Chem Biol. 2021;2(5):1352\u201369.","journal-title":"RSC Chem Biol"},{"issue":"11","key":"8356_CR59","doi-asserted-by":"publisher","first-page":"e184968","DOI":"10.1172\/jci.insight.184968","volume":"10","author":"L Ji","year":"2025","unstructured":"Ji L, Pu L, Wang JL, Cao HB, Melemenidis S, Sinha S, Guan L, Laseinde EE, Eyben RV, Richter SA, Nam JM, Kong C, Casey KM, Graves EE, Frock RL, Le QT, Rankin EB. FTO inhibition enhances the therapeutic index of radiation therapy in head and neck cancer. JCI Insight. 2025;10(11):e184968.","journal-title":"JCI Insight"},{"issue":"1","key":"8356_CR60","doi-asserted-by":"publisher","first-page":"4063","DOI":"10.1038\/s41467-025-59117-2","volume":"16","author":"YP Yen","year":"2025","unstructured":"Yen YP, Lung TH, Liau ES, Wu CC, Huang GL, Hsu FY, Chang M, Yang ZD, Huang CY, Zheng Z, Zhao W, Hung JH, He C, Nie Q, Chen JA. The motor neuron m6A repertoire governs neuronal homeostasis and FTO inhibition mitigates ALS symptom manifestation. Nat Commun. 2025;16(1):4063.","journal-title":"Nat Commun"},{"issue":"33","key":"8356_CR61","doi-asserted-by":"publisher","first-page":"eadv7648","DOI":"10.1126\/sciadv.adv7648","volume":"11","author":"WL Li","year":"2025","unstructured":"Li WL, Zhao YT, Wu D, Chen ZH, Qing Y, Yang F, Ji F, Zhang LD, Sau L, Chen JJ, He C. FTO degrader impairs ribosome biogenesis and protein translation in acute myeloid leukemia. Sci Adv. 2025;11(33):eadv7648.","journal-title":"Sci Adv"},{"key":"8356_CR62","doi-asserted-by":"publisher","first-page":"123168","DOI":"10.1016\/j.biomaterials.2025.123168","volume":"319","author":"H Tian","year":"2025","unstructured":"Tian H, Deng HP, Liu XL, Liu C, Zhang C, Leong KW, Fan XQ, Ruan J. A novel FTO-targeting nanodrug induces disulfidptosis and ameliorates the suppressive tumor immune environment to treat uveal melanoma. Biomaterials. 2025;319:123168.","journal-title":"Biomaterials"},{"issue":"1","key":"8356_CR63","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1038\/s41419-025-07494-3","volume":"16","author":"Z Dong","year":"2025","unstructured":"Dong Z, Li SY, Huang YM, Chen TZ, Ding YJ, Tan Q. RNA N(6)-methyladenosine demethylase FTO promotes diabetic wound healing through TRIB3-mediated autophagy in an m(6)A-YTHDF2-dependent manner. Cell Death Dis. 2025;16(1):222.","journal-title":"Cell Death Dis"},{"key":"8356_CR64","first-page":"e09524","volume":"2025","author":"C Wu","year":"2025","unstructured":"Wu C, Liu XF, Gu LW, Lian JR, Wang YT, Cheng YX, Duan LH, Huang GY, Chen SQ, Zhao BX, Liu SL, Yang YF, Zheng SQ, Lu ZJ, Guo WP, Hu JY, Wang WJ, Zuo ZX, Mai HQ, Tang LQ, Zhang SF, Wen FQ, Hong X, Guo L. The Tumor-to-Endothelial Transfer of FTO Promotes Vascular Remodeling and Metastasis in Nasopharyngeal Carcinoma. Adv Sci (Weinh). 2025;2025:e09524.","journal-title":"Adv Sci (Weinh)"},{"issue":"18","key":"8356_CR65","doi-asserted-by":"publisher","first-page":"8975","DOI":"10.3390\/ijms26188975","volume":"26","author":"JPN Silva","year":"2025","unstructured":"Silva JPN, Silva PMA, Bousbaa H. Kinesin Spindle Protein (KIF11) in Mitosis and Cancer. Int J Mol Sci. 2025;26(18):8975.","journal-title":"Int J Mol Sci"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-026-08356-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-026-08356-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-026-08356-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T02:03:38Z","timestamp":1785895418000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12967-026-08356-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,30]]},"references-count":65,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["8356"],"URL":"https:\/\/doi.org\/10.1186\/s12967-026-08356-y","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,30]]},"assertion":[{"value":"27 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This research was designed and performed in accordance with the principles of the Declaration of Helsinki (2013 version) and the Association for Research in Vision and Ophthalmology (ARVO) statement for research involving human subjects, and was approved by the Ethics Committee of the Affiliated Wuxi People\u2019s Hospital of Nanjing Medical University (KY24030, 2024\/03\/26). Animal experiments followed the Institutional Guidelines for the Humane Treatment of Animals, the Principles of Laboratory Animal Care (National Institutes of Health, Bethesda, MD, USA), and the ARVO Statement for the Use of Animals in Ophthalmic and Vision Research, and were approved by the Ethics Committee of The Affiliated Wuxi People\u2019s Hospital of Nanjing Medical University (DL2024-012, 2024\/06\/19).","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"994"}}